HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of John Farquhar as Chief Operating Officer, effective August 4. In this newly established role, Mr. Farquhar will support the execution of HeartFlow’s strategic vision.
“We are thrilled to add an executive of John’s caliber and accomplishments to the HeartFlow leadership team,” said John H. Stevens, MD, President, Chief Executive Officer and Co-Founder, HeartFlow. “In his new role, he will lead and provide strategic oversight of our key operational areas to ensure excellence and disciplined growth as HeartFlow continues to transform the diagnosis and management of coronary artery disease.”
Mr. Farquhar brings more than 20 years of experience providing strategic oversight to deliver operational excellence and outstanding performance. Most recently, he served as Vice President and General Manager of Medtronic’s Aortic business, delivering strong growth through new product launches. He also served in key leadership roles for Medtronic’s Cardiovascular and Diabetes Groups, including Vice President of the Americas region for the Insulin Pump and Continuous Glucose Monitoring business unit and Vice President for Asia Pacific.
“I am excited to join an innovative, high-growth company with a compelling vision to change the paradigm for managing and treating heart disease,” said Mr. Farquhar. “I look forward to working with the leadership team at HeartFlow to democratize access to this incredible technology.”
A native of California, Mr. Farquhar earned his BA from Duke University and his MBA from Northwestern’s Kellogg School of Management.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.
